Home > Press > eBioscience Announces an Expansion of the eFluor(TM) Brand with the Commercial Launch of eFluor(TM) Organic Dyes
![]() |
Abstract:
eBioscience Corporation, a leading global provider of innovative, high-quality cell analysis reagents, announced today the expansion of its eFluor(TM) brand with the commercial launch of the eFluor(TM) Organic Dye product line.
"We are very pleased to announce the addition of several novel organic dyes to our eFluor(TM) brand," said Todd R. Nelson Ph.D., CEO of eBioscience. "The development and commercialization of innovative, high-quality, multicolor cellular analysis research reagents remains a cornerstone of eBioscience's business," Nelson continued. "The addition of the organic dyes to our eFluor(TM) brand product line serves to both diversify our customer base and extend our reach into a rapidly growing segment of the market focused on multicolor applications."
"We are particularly excited about our ability to offer an increasing number of products, such as our eFluor(TM) 450 Organic Dye, as a replacement for Pacific Blue(R), providing our customers greater flexibility when choosing reagents for use in multicolor flow cytometry experiments," commented Tony Ward, VP Commercial Operations for eBioscience. "In addition, we are also launching a series of new APC eFluor(TM) 780 tandem conjugates that, because they have greater fluorescence intensity than competitor products, provide significant benefit to researchers designing multicolor cellular analysis experiments," Ward continued. Mike Boyer, Ph.D., eBioscience's Director of Marketing commented, "Taken together our rapidly expanding portfolio of eFluor(TM) Organic Dyes and nanocrystal reagents, when combined with our leading edge portfolio of biological content, facilitates our ability to keep eBioscience's customers at the forefront of scientific discovery."
With the launch of over 40 eFluor(TM) Organic Dye products, eBioscience Corporation is well positioned to offer to its customers an increasingly broad array of novel products that employ proprietary technologies optimized for use with standard reagents. Importantly, eFluor(TM) Organic Dyes have been designed and optimized for use with a variety of existing organic fluorochromes and nanocrystal technologies, including eBioscience's own eFluor(TM) Nanocrystals product line, and as such, provide optimal flexibility to researchers when designing multicolor experiments in the areas of flow cytometry, in vivo imaging and microscopy.
####
About eBioscience Corporation
eBioscience provides innovative high quality reagents to academic and government researchers and pharmaceutical and biotech companies worldwide that empower the process of scientific discovery in the areas of cellular immunity and oncology.
The company's extensive portfolio of more than 8,000 leading edge cell analysis reagents and technologies, focused on flow cytometry and immunodetection, position our customers to be at the forefront of science. eBioscience is aligned with and responsive to the ever changing needs of its customers, making the company a preferred partner for scientific discovery.
Founded in 1999, eBioscience is headquartered in San Diego, California and conducts business in more than 70 countries around the world.
For more information, please click here
Contacts:
eBioscience, Inc.
10255 Science Center Drive
San Diego, CA 92121
USA
Telephone Technical Support:
888.810.6168
Customer Service:
888.999.1371 or 858.642.2058
Fax 858.642.2046 (Fax)
Technical Support:
Customer Service:
Copyright © PR Newswire Association LLC.
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
| Related News Press |
News and information
Quantum computer improves AI predictions April 17th, 2026
Flexible sensor gains sensitivity under pressure April 17th, 2026
A reusable chip for particulate matter sensing April 17th, 2026
Detecting vibrational quantum beating in the predissociation dynamics of SF6 using time-resolved photoelectron spectroscopy April 17th, 2026
Imaging
Simple algorithm paired with standard imaging tool could predict failure in lithium metal batteries August 8th, 2025
Nanomedicine
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
UC Irvine physicists discover method to reverse ‘quantum scrambling’ : The work addresses the problem of information loss in quantum computing system April 17th, 2026
Nanobiotechnology
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
|
|
||
|
|
||
| The latest news from around the world, FREE | ||
|
|
||
|
|
||
| Premium Products | ||
|
|
||
|
Only the news you want to read!
Learn More |
||
|
|
||
|
Full-service, expert consulting
Learn More |
||
|
|
||